US FDA issues draft guidance on assessing drug abuse potential
This article was originally published in Scrip
Executive Summary
The US FDA has issued draft guidance for the industry, Assessment of Abuse Potential of Drugs, designed to assist manufacturers in developing drugs that have potential for abuse and that may need to be scheduled under the Controlled Substances Act.